edaravone has been researched along with Carcinoma, Hepatocellular in 1 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noda, S | 1 |
| Kawata, S | 1 |
| Ito, N | 1 |
| Miyoshi, S | 1 |
| Imai, Y | 1 |
| Saitoh, R | 1 |
| Tamura, S | 1 |
| Inada, M | 1 |
| Inui, Y | 1 |
| Matsuda, Y | 1 |
1 other study available for edaravone and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
[Alterations of urinary excretion of antipyrine metabolites in patients with cirrhosis of the liver].
Topics: Antipyrine; Carcinoma, Hepatocellular; Edaravone; Female; Humans; Liver Cirrhosis; Liver Neoplasms; | 1987 |